5 min read
Challenges for Medical Device Database Builds and Strategies to Overcome Them
What are some of the challenges with database builds for medical device studies, given the current regulatory requirements? What are the...
Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.
All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.
Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.
Purpose-built solutions. Proven results. User & Patient-centered innovation.
Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity. Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.
We are the Innovation CRO.
Legacy of excellence. Proven execution. Patient impact accelerated.
2 min read
Gary Keeler : Aug 8, 2022 11:26:56 AM
Many articles discussing the difference between drug and device trials come from a regulatory perspective on how clinical trials are designed and executed. We would like to discuss how differences between drug and device trials impact data management. Good quality data is a basic foundation for assessing both drug and medical devices.
Drug vs Device Issue | Medical Device Difference | Data Management (DM) Perspective |
---|---|---|
Population Studied | Selection of subjects may be more difficult in a device trial, especially for invasive procedures.
|
Data management activities important to provide:
|
Study Design | Placebo-controlled, double blind design features common in drug trials not suitable for most device trials.
Choice of efficacy endpoint important |
Data management activities essential to identify and generate good quality data for the assessment, by providing:
Endpoints may include imaging data or other data that requires a Data Adjudication Committee to review/agree on clinical endpoint outcomes
|
Safety Reporting and Regulatory Requirements | Regulatory guidelines for device safety reporting to provide data that reflect the risk profile of the device.
|
Data management activities must include capture of:
|
A key challenge for medical device companies is to find the right expertise, especially for database building and data management, whether using in-house resources, or a contract research organization (CRO) for their trial. Veranex has experience working with Medical Device companies for comprehensive services including the product design and engineering, testing, preclinical services, regulatory, and biometrics. We are here to help at any point in your commericalization pathway with end-to-end resources and expertise on staff available exactly when you need it.
5 min read
What are some of the challenges with database builds for medical device studies, given the current regulatory requirements? What are the...
The clinical research landscape is rapidly evolving, placing increased importance on robust and compliant clinical data management services (CDMS)....
5 min read
When a clinical trial faces data quality challenges, every day counts. Rescue studies have become an increasingly critical component in...